OSR Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by OSR Health, Inc. on August 7, 2026. The record date for the meeting was July 8, 2026, with 35,118,692 shares of common stock issued and outstanding. A quorum was established with 21,088,120 shares (approximately 60.05%) present in person or by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on four key proposals at the Annual Meeting:
- Director Election: Seven directors were re-elected to serve until the 2027 Annual Meeting. All candidates received significant support, with "For" votes ranging from approximately 15.17 million to 15.18 million out of the shares present.
- Ratification of Independent Auditor: Approved with 20,296,535 votes "For," 201,444 "Against," and 590,141 "Abstain."
- Executive Compensation: Approved with 15,059,135 votes "For," 83,113 "Against," and 161,533 "Abstain."
- Authorized Shares Increase: Approved with 19,922,498 votes "For," 581,009 "Against," and 584,613 "Abstain."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. Detailed descriptions of the proposals are referenced in the Definitive Proxy Statement on Form DEF 14A filed on July 16, 2026.
Key Facts for Investor Verification
- Verify the specific terms of the "Authorized Shares Increase Proposal" in the DEF 14A to understand the new share cap and potential dilution impact.
- Review the DEF 14A for details on the executive compensation plan that was approved by stockholders.
- Confirm the identity and background of the seven re-elected directors to assess board composition changes.
- Check subsequent filings for the official issuance of any new shares resulting from the authorized increase.